|
|
Article: Sunol Moves Sunol-cH36 Into Clinic; Fund-Raising In Works.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
Since the early 1990s, some employees of Sunol Molecular Corp. have been working in the area of tissue factor, even before the company was incorporated in 1995. Now, that long-term interest is becoming more focused with the start of Phase I trials.
Tissue factor, as described by Sunol, is "an integral membrane protein expressed on the surface of the subendothelial cells." In healthy people, tissue factor contributes to hemostasis, infection prevention and wound healing, Sunol said. But the Miramar, Fla.-based company's lead product is looking at its pathophysiological role in thrombosis, inflammation (including sepsis, acute respiratory ...